CORT vs VZ · P/E 199, rev $421.1M vs P/E 11, rev $34.25B
Corcept Therapeutics Incorporated (CORT) versus Verizon Communications Inc (VZ) — a side-by-side from cached financials, not a winner call.
Corcept Therapeutics Incorporated (CORT) is a biotechnology company listed on US.
Verizon Communications Inc (VZ) is a telecom services company listed on NYSE. It is led by Hans Vestberg.
Latest reported CORT revenue for 2026-06-30 was $421.1M. Net income was $11.2M. CORT currently screens at market cap $7.46B and trailing P/E 198.5.
Latest reported VZ revenue for 2026-06-30 was $34.25B. Net income was $3.83B. Revenue was down 0.5% from 2026-03-31 to 2026-06-30. VZ currently screens at market cap $191.41B and trailing P/E 11.2.
CORT currently screens at market cap $7.46B and trailing P/E 198.5. VZ currently screens at market cap $191.41B and trailing P/E 11.2.
Not investment advice. Open the CORT and VZ stock pages for the full models.
Not investment advice.